Attention is a cognitive process in which a person or animal concentrates on one thing in particular. To attend to something is to focus, heed or take notice of that thing irrespective of what ...

SF is a 50-year-old woman, counseled about the therapeutic use of psilocybin by her neurologist, who has participated in ...

Kokumi refers to the enhanced and more delicious state of food flavor. However, the underlying neuroscientific mechanisms remain largely unexplored. Our previous research demonstrated that ornithine ...

Cite this: TNF Signaling Inhibition in the CNS: Implications for Normal Brain Function and Neurodegenerative Disease - Medscape - Oct 17, 2008.

A 1 AR Brain (cortex, hippocampus, cerebellum), spinal cord, eye, adrenal gland, atria, liver, kidney, adipose tissue, salivary glands, esophagus, colon, atrium and ...

Sage Therapeutics has been working in the area of steroid-derived compounds that affect CNS receptor signaling. A pivotal trial failed to show benefit, and they had several other clinical failures ...

announced new data from its IM-PROVE I Phase 2a clinical trial showing that six doses of imdusiran, the company’s RNAi therapeutic candidate, and 24 weeks of pegylated interferon alfa-2a ...

With positive results, Phase 2a proof-of-concept study expected to ... company addressing diseases of the central nervous system (CNS), today announced the initiation of dosing in a Phase 1 ...

(Nasdaq: RLMD, “Relmada”, “the Company”), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today ... the way for a Phase 2a proof-of-concept ...

Incorporating this technique into future studies could enable the precise evaluation of myelin integrity in models of demyelination, further elucidating the role of ion channels and metabotropic ...

After all, these share the same MoA that suppresses the CB1 receptor to reduce appetite and fat accumulation. Moreover, CNS-related side ... (other than from Seeking Alpha). I have no business ...